baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Neovacs SA/ FR001400MV37 /

2024-11-12 5:35:27 PM	Chg. 0.0000	Volume	Bid5:40:00 PM	Ask5:35:49 PM	High	Low
0.0002EUR	0.00%	108.4 mill. Turnover: 21,922.8601	0.0001Bid Size: 509.21 mill.	0.0002Ask Size: 27.5 mill.	0.0003	0.0002

GlobeNewswire 2019-07-29 Unum Therapeutics Announces New Appointments to its Board of Directors

TeleTrader 2019-02-11 Euronext reports technical glitch in market data

GlobeNewswire 2019-01-08 NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE IL-4/I...

GlobeNewswire 2018-12-11 Neovacs and Centurion Pharma continue their collaboration in Lupus based on the results of the Phase...

GlobeNewswire 2018-11-20 Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vacci...

GlobeNewswire 2018-11-15 Human Vaccines - 2018 Global Strategic Business Report Covering 2016-2024: Increasing Need for Vacci...

GlobeNewswire 2018-11-07 Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vac...

GlobeNewswire 2018-10-30 NEOVACS : HALF-YEAR 2018 FINANCIAL RESULTS

GlobeNewswire 2018-10-11 NEOVACS ANNOUNCES THE CONTINUATION OF THE DEVELOPMENT OF ITS IFNalpha KINOID IN SOUTH KOREA WITH ITS...

GlobeNewswire 2018-09-11 NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE...

GlobeNewswire 2018-07-03 NEOVACS ANNOUNCES THE RESULTS OF ITS PHASE IIB STUDY FOR IFNalpha KINOID IN THE TREATMENT OF LUPUS

GlobeNewswire 2018-05-15 NEOVACS STRENGTHENS INTELLECTUAL PROPERTY POSITION IN EUROPE AND JAPAN

GlobeNewswire 2018-03-30 NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS

GlobeNewswire 2018-02-22 NEOVACS STRENGTHENS ITS INTELLECTUAL PROPERTY IN THE USA

GlobeNewswire 2018-02-21 Back of the Eye Disorders Markets, 2030

GlobeNewswire 2018-02-16 NEOVACS :2018 Financial Calendar

GlobeNewswire 2018-02-13 Neovacs Announces Positive Data Review from Last IDSMB Review Prior to Final Results of Phase IIb Cl...

GlobeNewswire 2018-01-16 NEOVACS : STRENGTHENED ITS INTELLECTUAL PROPERTY IN RUSSIA

GlobeNewswire 2018-01-05 miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris

GlobeNewswire 2017-12-12 NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES

GlobeNewswire 2017-10-30 ERRATUM: NEOVACS PROVIDES BUSINESS UPDATE AND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS

GlobeNewswire 2017-10-27 NEOVACS PROVIDES BUSINESS UPDATE AND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS

GlobeNewswire 2017-08-04 NEOVACS ANNOUNCES THE CLOSING OF A €6.0 MILLION PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIO...

GlobeNewswire 2017-07-31 NEOVACS : SUCCESSFULLY RAISES €6.0 MILLION IN PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONA...

GlobeNewswire 2017-07-19 Neovacs Announces FDA Acceptance of a New IND to Expand in U.S. IFNalpha Kinoid Clinical Development...

Neovacs SA/ FR001400MV37 /

If you wish to receive reply to your feedback, please provide your email address.